The glycomics market involves products and services used for the study of the entire complement of sugars or glycans in cells, tissues, and organisms. Glycomics involves the study of structure, function, and interactions of glycans. Key products in the glycomics market include glycan labeling kits, glycan purification kits, glycan analysis instruments, glycan standards, reagents and chemicals, software & services. Glycomics research and products play a crucial role in the drug discovery process through identifying potential glycoprotein drug candidates and understanding their mechanisms of action.

The Global Glycomics Market Size is estimated to be valued at US$ 1.99 Billion in 2024 and is expected to exhibit a CAGR of 13% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the glycomics market are RayBiotech Life, Inc., Shimadzu Corporation, Asparia Glycomics, Agilent Technologies Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Merck KgaA, New England Biolabs, Takara Bio Inc, Waters Corporation, Danaher, Lectenz Bio, GlycoMimetics, Inc., Ludger Ltd., GlycoTech Corporation, Glycosyn LLC, Glykos, Inc., and Glanbia PLC. With growing applications of glycoproteins in therapeutics development, key players are investing in development of improved glycan analysis and purification solutions to aid efficient drug discovery processes.

The global glycomics market is witnessing significant growth due to increasing demand for glycoprotein therapeutics and biopharmaceuticals. Glycoproteins have proven therapeutic efficacy in various disease conditions such as cancers and genetic disorders. This growing clinical importance of glycoproteins is driving demand for efficient glycomics research solutions.

Major players are also focused on expanding their global footprint through partnerships and new facilities to cater to the growing demand from pharmaceutical and biotechnology companies globally. For instance, in 2021, Bruker Corporation established a new product development and application laboratory for glycomics research in New Zealand. This expansion was aimed at supporting global glycomics research initiatives.

Market drivers
Growing clinical focus on glycoprotein therapeutics is one of the key drivers of the glycomics market. With robust glycomics research capabilities, pharmaceutical companies are progressing towards development of effective and safer protein and peptide drugs. Glycomics helps in identification and isolation of promising glycoprotein candidates as well as understanding their structure-function properties which aids development of novel biologics. This increasing shift towards glycoprotein drugs is expected to propel the glycomics market during the forecast period.

The current geopolitical situation is having a significant impact on the growth of the glycomics market. Political instability and economic uncertainties in various parts of the world have disrupted supply chains and made it challenging for companies to transport materials and components across borders smoothly. This is hindering research activities in the glycomics field to some extent. Additionally, international collaborations and exchange of knowledge between scientists have become more difficult due to travel restrictions and shutdowns during the pandemic.

Get More Insights On This Topic: Glycomics Market

Explore More Related Topic: Glycomics Market